Pulmonary resection after concurrent chemotherapy and high dose (60 Gy) radiation for non-small cell lung cancer is safe and may provide increased survival

European Journal of Cardio-thoracic Surgery

Volumn 35, Issue 4, 2009, Pages 718-723

  Cerfolio, Robert James ^a   Bryant, Ayesha S ^a   Jones, Virginia L ^b   Cerfolio, Robert Michael ^b  

^a Kentucky   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Non small cell lung cancer; Pulmonary resection; Radiation

Indexed keywords

CARBOPLATIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DATA BASE; ECHOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MUSCLE FLAP; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORACOTOMY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 62149134925     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.12.029     Document Type: Article

References (26)

1. International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 2004;350:351-60.
2. Winton T., Livingston R., Johnson D., Rigas J., Johnston M., Butts C., Cormier Y., Goss G., Inculet R., Vallieres E., Fry W., Bethune D., Ayoub J., Ding K., Seymour L., Graham B., Tsao M.S., Gandara D., Kesler K., Demmy T., Shepherd F., National Cancer institute of Canada Clinical Trials Group, and National Cancer Institute of a United States Intergroup JBR 10 Trial Investigators. Vinorelbine and cisplatin vs observation in resected non-small cell lung cancer. N Engl J Med 352 (2005) 2589-2597
3. Douillard J.-Y., Rosell R., Delena M., Legroumellec A., Torres A., and Carpagnano F. Adjuvant Navelbine International Trialist Association. ANITA: phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in complete resected (stage I-III) non-small cell lung cancer (NSCLC) patients: final results after 70-month medial follow up. J Clin Oncol 23 (2005) 624S [abstract 7013]
4. Robinson LA, Ruckdeschel JC, Wagner H, Stevens CW. Treatment of non-small cell lung cancer stage IIIA. ACCP evidence-based clinical practice guidelines (second edition). Chest 2007;132:243S-65S.
5. Cerfolio R.J., and Bryant A.S. Survival of patients with unsuspected N2 (stage IIIA) non-small cell lung cancer. Ann Thorac Surg 86 (2008) 362-366
6. Cerfolio R.J., Bryant A.S., Spencer S.A., and Bartolicci A.A. Pulmonary resection after high-dose and low-dose chest irradiation. Ann Thorac Surg 80 (2005) 1224-1230
7. Furuse K., Fukuoka M., Kawahaa M., Nishikawa H., Takada Y., Kudoh S., Katagami N., and Ariyoshi Y. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
8. Curran W.J., Scott C., Langer G., and Keller S.M. Phase III comparison of sequential vs concurrent chemo radiation for patients with unresectable stage III non-small cell lung cancer. Initial report of RTOG 9410. Proc Am Soc Clin Oncol 19 (2000) 484a
9. Fowler W.C., Langer C.J., Curran Jr. W.J., and Keller S.M. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55 (1993) 986-989
10. Rusch V.W., Albain K.S., Crowley J.J., Rice T.W., Lonchyna V., McKenna Jr. R., Livingston R.B., Griffin B.R., and Benfield J.R. Surgical resection of stage IIIa and stage IIIb non-small cell lung cancer after concurrent induction chemoradiotherapy. J Thorac Cardiovasc Surg 105 (1993) 96-106
11. Sugarbaker DG, Herndon J, Kohman LJ, Krasna MJ, Green MR, the Cancer and Leukemia Group B Thoracic Surgery Group, Sponsored by Valerie Rusch. Results of cancer and leukemia group B protocol 8935. A multi-institutional phase III trimodality trial for stage IIIA (N2) non-small-cell lung cancer. J Thorac Cardiovasc Surg 1995;109:473-85.
12. Pisters K.M., Ginsberg R.J., Giroux D.J., Putnam Jr. J.B., Kris M.G., Johnson D.H., Roberts J.R., Mault J., Crowley J.J., Bunn Jr. P.A., and Bimodality Lung Oncology Team. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. J Thorac Cardiovasc Surg 119 (2000) 429-439
13. Cerfolio R.J., and Bryant A.S. When is it best to repeat a 2-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan on patients with non-small cell lung cancer who have received neoadjuvant chemoradiotherapy?. Ann Thorac Surg 84 October (4) (2007) 1092-1097
14. Cerfolio R.J., Bryant A.S., and Maniscalco L.M. A nondivided intercostal muscle flap further reduces pain of thoracotomy: a prospective randomized trial. Ann Thorac Surg 85 June (6) (2008) 1901-1906
15. Cerfolio R.J., Bryant A.S., Patel B., and Bartolucci A.A. Intercostal muscle flap reduces the pain of thoracotomy: a prospective randomized trial. J Thorac Cardiovasc Surg 130 4 (2005) 987-993
16. Cerfolio R.J., Price T.N., Bryant A.S., Sales Bass C., and Bartolucci A.A. Intracostal sutures decrease the pain of thoracotomy. Ann Thorac Surg 76 August (2) (2003) 407-411
17. Cerfolio R.J., Bryant A.S., Bass C.S., and Bartolucci A.A. A prospective, double-blinded, randomized trial evaluating the use of preemptive analgesia of the skin before thoracotomy. Ann Thorac Surg 76 (2003) 1055-1058
18. Mountain C.F. The international system for staging lung cancer. Semin Surg Oncol 18 March (2) (2000) 106-115
19. Cerfolio RJ, Bryant AS. The analysis of a prospective surgical database improves post-operative, fast-tracking algorithms after pulmonary resection. Presented at AATS, J Thorac Cardiovasc Surg, in press.
20. Kraut M.J., Rusch V.W., and Crowley J.J. Induction chemoradiotherapy plus surgical resection is a feasible and highly effective treatment for Pancoast tumors: initial results of SWOG 9416 (intergroup 0160) trial. Proc Am Soc Clin Oncol 19 (2000) 487a
21. Albain K.S., Rusch V.W., Crowley J.J., Rice T.W., Turrisi III A.T., Weick J.K., Lonchyna V.A., Presant C.A., McKenna R.J., and Gandara D.R. Concurrent cisplatinum/etopiside plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of southwest oncology group phase II study 8805. J Clin Oncol 13 (1995) 1880-1892
22. Albain KS, Scott CB, Rusch VW, Turrisi AT, Shepherd FA, Smith C, Gandara DR, Johnson D, Green MR, Miller RC. Phase III comparison of concurrent chemotherapy plus radiotherapy and CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): initial results from the intergroup trial 0139 (RTOG93-09). ASCO, Abstract 2003.
23. Sonett J.R., Krasna M.J., Suntharalingam M., Schuetz J., Doyle L.A., Lilenbaum R., and Gamliel Z. Safe Pulmonary resection after chemotherapy and high-dose thoracic radiation. Ann Thorac Surg 68 (1999) 316-320
24. Sonett J.R., Suntharalingam M., Edelman M.J., Patel A.B., Gamliel Z., Doyle A., Hausner P., and Krasna M. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Ann Thorac Surg 78 (2004) 1200-1206
25. Suntharalingam M., Sonett J.R., Haas M.L., Doyle L.A., Hausner P.F., Schuetz J., and Krasna M.J. The use of concurrent chemotherapy with high dose radiation prior to surgical resection in patients presenting with apical sulcus tumors. Cancer J Sci Am 6 (2000) 365-371
26. Cerfolio R.J., Bryant A.S., and Yamamuro M. Intercostal muscle flap to buttress the bronchus at risk and the thoracic esophageal-gastric anastomosis. Ann Thorac Surg 80 (2005) 1017-1020